{"id":1532,"date":"2013-11-06T12:56:46","date_gmt":"2013-11-06T02:56:46","guid":{"rendered":"https:\/\/theveterinarian.com.au\/?p=1532"},"modified":"2013-10-09T12:57:51","modified_gmt":"2013-10-09T02:57:51","slug":"pfizer-to-close-sydney-plant","status":"publish","type":"post","link":"https:\/\/theveterinarian.com.au\/?p=1532","title":{"rendered":"Pfizer to close Sydney plant"},"content":{"rendered":"Veterinary and human drug pharmaceutical company Pfizer plans to close its Sydney manufacturing plant in two years.\r\n\r\nThe company&#8217;s Perth plant will not close.\r\n\r\nPfizer Australia has announced a phased exit of its West Ryde plant, affecting about 140 employees.\r\n\r\nThe plant produces tablets and capsules for animals and humans.\r\n\r\nManufacturing operations director Justin Mathie said the decision had been difficult and reflected the need to align the company&#8217;s global manufacturing capacity with its business needs.\r\n\r\n\u201cOur focus in the months ahead will be on colleagues impacted by the decision as well as ensuring we continue to make Pfizer medicines available in Australia,\u201d he said.\r\n\r\nThe pharmaceutical industry was trending away from high-volume medicines to those of higher value which targeted a specific patient population or disease.\r\n\r\n\u201cThis requires more flexible manufacturing facilities and a different overall approach to manufacturing.\u201d\r\n\r\nHe said most workers would not be impacted until 2015.\r\n\r\nPfizer employs more than 1600 people in its Australian operations","protected":false},"excerpt":{"rendered":"<p>Veterinary and human drug pharmaceutical company Pfizer plans to close its Sydney manufacturing plant in two years. The company&#8217;s Perth plant will not close. Pfizer Australia has announced a phased exit of its West Ryde plant, affecting about 140 employees. The plant produces tablets and capsules for animals and humans. Manufacturing operations director Justin Mathie [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[664,5],"tags":[694,1315,1316,1317,1313,1314,799],"class_list":["post-1532","post","type-post","status-publish","format-standard","hentry","category-business","category-news","tag-business-2","tag-closure","tag-factory","tag-manufacturing","tag-pfizer","tag-plant","tag-sydney"],"rise-blocks_total_comments":0,"rise-blocks_categories":[{"term_id":664,"name":"Business","slug":"business","term_group":0,"term_taxonomy_id":666,"taxonomy":"category","description":"","parent":0,"count":18,"filter":"raw","cat_ID":664,"category_count":18,"category_description":"","cat_name":"Business","category_nicename":"business","category_parent":0},{"term_id":5,"name":"News","slug":"news","term_group":0,"term_taxonomy_id":5,"taxonomy":"category","description":"","parent":0,"count":402,"filter":"raw","cat_ID":5,"category_count":402,"category_description":"","cat_name":"News","category_nicename":"news","category_parent":0}],"rise-blocks_excerpt":"Veterinary and human drug pharmaceutical company Pfizer plans to close its Sydney manufacturing plant in two years. The company&#8217;s Perth plant will not close. Pfizer Australia has announced a phased exit of its West Ryde plant, affecting about 140 employees. The plant produces tablets and capsules for animals and humans. Manufacturing operations director Justin Mathie said the decision had been..","blog_post_layout_featured_media_urls":{"thumbnail":"","full":""},"categories_names":{"664":{"name":"Business","link":"https:\/\/theveterinarian.com.au\/?cat=664"},"5":{"name":"News","link":"https:\/\/theveterinarian.com.au\/?cat=5"}},"tags_names":{"694":{"name":"business","link":"https:\/\/theveterinarian.com.au\/?tag=business-2"},"1315":{"name":"closure","link":"https:\/\/theveterinarian.com.au\/?tag=closure"},"1316":{"name":"factory","link":"https:\/\/theveterinarian.com.au\/?tag=factory"},"1317":{"name":"manufacturing","link":"https:\/\/theveterinarian.com.au\/?tag=manufacturing"},"1313":{"name":"Pfizer","link":"https:\/\/theveterinarian.com.au\/?tag=pfizer"},"1314":{"name":"plant","link":"https:\/\/theveterinarian.com.au\/?tag=plant"},"799":{"name":"Sydney","link":"https:\/\/theveterinarian.com.au\/?tag=sydney"}},"comments_number":"0","wpmagazine_modules_lite_featured_media_urls":{"thumbnail":"","cvmm-medium":"","cvmm-medium-plus":"","cvmm-portrait":"","cvmm-medium-square":"","cvmm-large":"","cvmm-small":"","full":""},"_links":{"self":[{"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=\/wp\/v2\/posts\/1532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1532"}],"version-history":[{"count":1,"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=\/wp\/v2\/posts\/1532\/revisions"}],"predecessor-version":[{"id":1533,"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=\/wp\/v2\/posts\/1532\/revisions\/1533"}],"wp:attachment":[{"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theveterinarian.com.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}